Completed PHASE4 INTERVENTIONAL 2-arm NCT02644707

Selenium Supplementation in Youths With Autoimmune Thyroiditis (THYROSEL)

L-selenomethionine Supplementation in Children and Adolescents With Autoimmune Thyroiditis: a Randomized Blind Placebo-controlled Clinical Trial

Sponsor: Aristotle University Of Thessaloniki

Conditions Autoimmune Thyroiditis

Interventions L-selenomethionine Placebo

Updated 7 times since 2017 Last updated: Jan 31, 2020 Started: Aug 31, 2014 Primary completion: Oct 31, 2016 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Autoimmune Thyroiditis and is currently completed. Aristotle University Of Thessaloniki leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Mar 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jun 2018 — Mar 2020 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting PHASE4

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aristotle University Of Thessaloniki

Data source: Aristotle University Of Thessaloniki

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Thessaloniki, Greece